• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2008 - 2013年五个州非结核分枝杆菌感染患病率上升

Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.

作者信息

Donohue Maura J, Wymer Larry

机构信息

U.S. Environmental Protection Agency, Office of Research and Development, National Exposure Research Laboratory, Cincinnati, Ohio.

出版信息

Ann Am Thorac Soc. 2016 Dec;13(12):2143-2150. doi: 10.1513/AnnalsATS.201605-353OC.

DOI:10.1513/AnnalsATS.201605-353OC
PMID:27681202
Abstract

RATIONALE

Many nontuberculous mycobacteria (NTM) are clinically significant pathogens that cause disease in a variety of different human organs and tissues.

OBJECTIVES

A population-based study was undertaken to investigate the prevalence of patients with a positive specimen for NTM within five states of the United States.

METHODS

We determined the case and age distribution of patients with at least one specimen positive for NTM, using data submitted to the disease surveillance systems of five states (Maryland, Mississippi, Missouri, Ohio, and Wisconsin) between 2008 and 2013. Crude, age-specific, and age-adjusted prevalence rates per 100,000 persons were calculated for each state.

MEASUREMENTS AND MAIN RESULTS

From 2008 to 2013, a total of 24,226 NTM cases were reported to the disease surveillance systems of the five states. The overall average annual age-adjusted prevalence rate rose from 8.7 to 13.9 per 100,000 persons between the beginning and end of the surveillance period. The number of cases and case rate in the 50-80+-year age group was higher than in the 0-49-year age group. Prevalence by age category differed among the five states. The highest number of NTM cases was observed in Mississippi for the 80+-year age group, whereas Wisconsin observed the highest number of NTM cases in the 60- to 69-year age group.

CONCLUSIONS

From 2008 to 2013, the number of patients with positive specimens for NTM rose. This trend is likely to continue in the coming decade as the U.S. population ages. To reduce the prevalence of NTM infections, medical guidance for susceptible populations is needed regarding actions that can be taken to avoid sources and routes of exposure to NTMs if the disease burden is to be reduced.

摘要

原理

许多非结核分枝杆菌(NTM)是具有临床意义的病原体,可在人类各种不同的器官和组织中引发疾病。

目的

开展一项基于人群的研究,以调查美国五个州NTM检测呈阳性的患者的患病率。

方法

我们利用2008年至2013年间提交至五个州(马里兰州、密西西比州、密苏里州、俄亥俄州和威斯康星州)疾病监测系统的数据,确定了至少有一份NTM检测呈阳性的患者的病例及年龄分布情况。计算了每个州每10万人的粗患病率、年龄别患病率和年龄调整患病率。

测量指标及主要结果

2008年至2013年期间,五个州的疾病监测系统共报告了24226例NTM病例。在监测期开始和结束时,总体年均年龄调整患病率从每10万人8.7例升至13.9例。50至80岁以上年龄组的病例数和发病率高于0至49岁年龄组。五个州按年龄分类的患病率有所不同。在80岁以上年龄组中,密西西比州的NTM病例数最多,而在60至69岁年龄组中,威斯康星州的NTM病例数最多。

结论

2008年至2013年期间,NTM检测呈阳性的患者数量有所增加。随着美国人口老龄化,这一趋势在未来十年可能会持续。为降低NTM感染的患病率,如果要减轻疾病负担,需要为易感人群提供关于可采取哪些行动来避免接触NTM的来源和途径的医学指导。

相似文献

1
Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.2008 - 2013年五个州非结核分枝杆菌感染患病率上升
Ann Am Thorac Soc. 2016 Dec;13(12):2143-2150. doi: 10.1513/AnnalsATS.201605-353OC.
2
Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance - Oregon, 2014-2016.肺外非结核分枝杆菌病监测 - 俄勒冈州,2014-2016 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):854-857. doi: 10.15585/mmwr.mm6731a3.
3
Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.北卡罗来纳州中部居民中分离出的非结核分枝杆菌的流行病学研究,2006-2010 年。
J Infect. 2016 Jun;72(6):678-686. doi: 10.1016/j.jinf.2016.03.008. Epub 2016 Mar 18.
4
Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports.提高临床实验室报告中报告的非结核分枝杆菌的检出率和物种多样性。
BMC Infect Dis. 2018 Apr 10;18(1):163. doi: 10.1186/s12879-018-3043-7.
5
Epidemiological risk factors and the geographical distribution of eight Mycobacterium species.八种分枝杆菌属菌种的流行病学风险因素及地理分布
BMC Infect Dis. 2021 Mar 12;21(1):258. doi: 10.1186/s12879-021-05925-y.
6
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.2007年至2012年俄勒冈州非结核分枝杆菌肺病的人群发病率
Ann Am Thorac Soc. 2015 May;12(5):642-7. doi: 10.1513/AnnalsATS.201412-559OC.
7
Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.日本非结核分枝杆菌肺病患者的成人和儿童治疗的流行病学。
Ann Am Thorac Soc. 2019 Mar;16(3):341-347. doi: 10.1513/AnnalsATS.201806-366OC.
8
Prevalence and species spectrum of both pulmonary and extrapulmonary nontuberculous mycobacteria isolates at a tertiary care center.一家三级医疗中心肺内和肺外非结核分枝杆菌分离株的患病率及菌种谱
Int J Mycobacteriol. 2016 Sep;5(3):288-293. doi: 10.1016/j.ijmyco.2016.06.008. Epub 2016 Jun 27.
9
Nontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century.丹麦的非结核分枝杆菌,过去 25 年来的发病情况和临床重要性。
Sci Rep. 2017 Jul 27;7(1):6696. doi: 10.1038/s41598-017-06931-4.
10
Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions.美国附属太平洋岛屿司法管辖区呼吸道标本中非结核分枝杆菌的流行率不断增加。
Emerg Infect Dis. 2018 Mar;24(3):485-491. doi: 10.3201/eid2403.171301.

引用本文的文献

1
Clinical Outcomes of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-cell Therapy in Patients With Antecedent Complex Pulmonary Disease: A Case Series of 8 Patients.既往患有复杂肺部疾病患者的造血细胞移植和嵌合抗原受体T细胞疗法的临床结局:8例病例系列研究
Open Forum Infect Dis. 2025 May 2;12(5):ofaf268. doi: 10.1093/ofid/ofaf268. eCollection 2025 May.
2
Apoptosis inhibitor of macrophage suppress immune responses via IL-10 production and delay bacterial clearance in infection.巨噬细胞凋亡抑制剂通过产生白细胞介素-10抑制免疫反应并延缓感染中细菌的清除。
Front Cell Infect Microbiol. 2025 May 5;15:1578082. doi: 10.3389/fcimb.2025.1578082. eCollection 2025.
3
Relationship between age, sex, geography and incidence of nontuberculous mycobacteria in Denmark from 1991 to 2022.
1991年至2022年丹麦非结核分枝杆菌的年龄、性别、地理位置与发病率之间的关系。
ERJ Open Res. 2025 Mar 3;11(2). doi: 10.1183/23120541.00437-2024. eCollection 2025 Mar.
4
Genetic Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease (Systematic Review).非结核分枝杆菌肺病的遗传风险因素(系统评价)
Sovrem Tekhnologii Med. 2024;16(5):62-71. doi: 10.17691/stm2024.16.5.07. Epub 2024 Oct 30.
5
Editorial: Nontuberculous mycobacterial infections in animals and humans: pathogenesis, diagnosis, prevention, treatment, and epidemiology.社论:动物和人类的非结核分枝杆菌感染:发病机制、诊断、预防、治疗及流行病学
Front Vet Sci. 2024 Dec 10;11:1532801. doi: 10.3389/fvets.2024.1532801. eCollection 2024.
6
Creeping Cold Nodules: Ascending Lower Extremity Nodules in an Immunocompromised Patient.匐行性冷结节:免疫功能低下患者下肢结节上行
Cureus. 2024 Sep 19;16(9):e69721. doi: 10.7759/cureus.69721. eCollection 2024 Sep.
7
The Intriguing Pattern of Nontuberculous Mycobacteria in Bulgaria and Description of sp. nov.保加利亚非结核分枝杆菌的有趣模式及 sp. nov. 的描述
Int J Mol Sci. 2024 Sep 27;25(19):10434. doi: 10.3390/ijms251910434.
8
Characterization of non-tuberculous mycobacterial pulmonary disease and pulmonary tuberculosis in patients with AFB smear-positive sputum: A retrospective comparative study.痰涂片抗酸杆菌阳性患者中非结核分枝杆菌肺病与肺结核的特征:一项回顾性比较研究。
Heliyon. 2024 Sep 4;10(17):e37434. doi: 10.1016/j.heliyon.2024.e37434. eCollection 2024 Sep 15.
9
The use of dual β-lactams to restore susceptibility of complex.使用双重β-内酰胺类药物来恢复复杂感染的敏感性。
JAC Antimicrob Resist. 2024 Sep 13;6(5):dlae142. doi: 10.1093/jacamr/dlae142. eCollection 2024 Oct.
10
Nontuberculous mycobacterial infection in Wisconsin children and adolescents.威斯康星州儿童和青少年的非结核分枝杆菌感染
J Clin Tuberc Other Mycobact Dis. 2024 Jun 12;36:100456. doi: 10.1016/j.jctube.2024.100456. eCollection 2024 Aug.